Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Mise à jour : Il y a 4 ans
Référence : NCT00728585

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

RATIONALE: Palifermin may help relieve or prevent oral mucositis caused by chemotherapy and radiation therapy in young patients undergoing stem cell transplant. PURPOSE: This randomized phase II trial is studying palifermin to see how well it works compared with a placebo in preventing oral mucositis caused by chemotherapy and/or radiation therapy in young patients undergoing stem cell transplant.


Critère d'inclusion

  • Breast Cancer,Graft-versus-host disease,Kidney Cancer,leukemia,LYMPHOMA,mucositis,Multiple myeloma,Plasma Cell Neoplasm,Myelodysplastic syndromes,Neuroblastoma,Ovarian Cancer,Sarcoma,Testicular Germ Cell Tumor

Liens